✦ LIBER ✦

The emerging role of Lapatinib in HER2-positive breast cancer

✍ Scribed by Alice Ulhoa-Cintra; Larisa Greenberg; Charles E. Geyer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of lapatinib

✍ Quang A. Le; Joel W. Hay 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

Targeting HER 1 and 2 in breast cancer w

✍ Gerald M. Higa 📂 Article 📅 2008 🏛 PAGEPress Publications 🌐 English ⚖ 119 KB

Lapatinib Distribution in HER2 Overexpre

✍ Kunal S. Taskar; Vinay Rudraraju; Rajendar K. Mittapalli; Ramakrishna Samala; He 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 749 KB

High serum TGF-α predicts poor response

✍ Jiyoung Rhee; Sae-Won Han; Yongjun Cha; Hye Seon Ham; Hwang-phill Kim; Do-Youn O 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 443 KB

The Role of Lapatinib in the Preoperativ

✍ Rebecca L. Hirsh; Angela DeMichele 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 94 KB

Randomized phase II study of lapatinib p

✍ Nancy U. Lin; Wolfgang Eierman; Richard Greil; Mario Campone; Bella Kaufman; Kla 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 189 KB